Codexis, Inc. (CDXS) vs Protara Therapeutics, Inc. (TARA)
A side-by-side comparison of Codexis, Inc. and Protara Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDXS
Codexis, Inc.
$1.36HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TARA
Protara Therapeutics, Inc.
$2.56HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CDXS vs TARA
growth of $100 · dividends reinvested · last 10yCDXS -68.6% (-10.9%/yr)TARA -99.3% (-38.8%/yr)CDXS compounded faster over this window
Log scale — wide-divergence pair
CDXS TARA
CDXS vs TARA: by the numbers
- •CDXS is the larger company ($146M vs $144M market cap).
- •Both run net losses; TARA's is the smaller (0.00% vs -39.55% net margin).
Metrics side by side
Valuation
| Metric | CDXS | TARA |
|---|---|---|
| P/S ratio | 1.88 | N/A |
| P/B ratio | 4.44 | 0.89 |
Profitability
| Metric | CDXS | TARA |
|---|---|---|
| Gross margin | 83.71% | 0.00% |
| Operating margin | -54.46% | 0.00% |
| Net margin | -39.55% | 0.00% |
| ROE | -93.22% | -43.40% |
| ROIC | -23.41% | -47.18% |
Growth (annualized)
| Metric | CDXS | TARA |
|---|---|---|
| Revenue CAGR (5Y) | 0.38% | N/A |
| Total return CAGR (5Y) | -44.64% | -16.45% |
Frequently asked
- How have CDXS and TARA total returns compared?
- Over the past 10 years, CDXS delivered -11.05% and TARA delivered -38.82% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.